Last update 25 Oct 2025

177Lu-TATE-RGD

Overview

Basic Info

Drug Type
Radionuclide Drug Conjugates (RDC), Therapeutic radiopharmaceuticals
Synonyms-
Target
SSTR2 x αvβ3
Action
modulators
Mechanism
SSTR2 modulators(Somatostatin receptor 2 modulators), αvβ3 modulators(Integrin alpha-V/beta-3 modulators)
Therapeutic Areas
NeoplasmsCongenital DisordersDigestive System Disorders+ [1]
Active Indication
Adenomatous Polyposis ColiNeuroendocrine Tumors
Inactive Indication-
Originator Organization
Peking Union Medical College Hospital
Active Organization
Peking Union Medical College Hospital
Inactive Organization-
License Organization-
Drug Highest PhaseEarly Phase 1
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Boost your research with our ADC technology data.
login
or
view full example data
Boost your research with our ADC technology data.

Related

1
Clinical Trials associated with 177Lu-TATE-RGD
NCT06632873
/ RecruitingEarly Phase 1IIT
Therapeutic Efficiency and Response to 177Lu-TATE-RGD in Patients With SSTR2 and Integrin αVβ3 Positive Tumors
100 Clinical Results associated with 177Lu-TATE-RGD
Login to view more data
100 Translational Medicine associated with 177Lu-TATE-RGD
Login to view more data
100 Patents (Medical) associated with 177Lu-TATE-RGD
Login to view more data
100 Deals associated with 177Lu-TATE-RGD
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Adenomatous Polyposis ColiPhase 1
China
Peking Union Medical College Hospital
01 Sep 2024
Neuroendocrine TumorsPhase 1
China
Peking Union Medical College Hospital
01 Sep 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free